OneCyte and Kemp Proteins partner to accelerate high-performance cell line development for next-generation biologics: Cambridge, Massachusetts Monday, April 6, 2026, 12:00 Hrs [IS ...
Ascletis Pharma Inc., a fully integrated biotechnology company, announces completion of enrollment in its US 13-week phase IIa study evaluating ASC30, a small molecule oral GLP-1 receptor (GLP-1R) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results